title: Cancer in experimental animals exposed to arsenic and arsenic compounds.
abstract: Inorganic arsenic is a ubiquitous environmental contaminant that has long been considered a human carcinogen. Recent studies raise further concern about the metalloid as a major, naturally occurring carcinogen in the environment. However, during this same period it has proven difficult to provide experimental evidence of the carcinogenicity of inorganic arsenic in laboratory animals and, until recently, there was considered to be a lack of clear evidence for carcinogenicity of any arsenical in animals. More recent work with arsenical methylation metabolites and early life exposures to inorganic arsenic has now provided evidence of carcinogenicity in rodents. Given that tens of millions of people worldwide are exposed to potentially unhealthy levels of environmental arsenic, in vivo rodent models of arsenic carcinogenesis are a clear necessity for resolving critical issues, such as mechanisms of action, target tissue specificity, and sensitive subpopulations, and in developing strategies to reduce cancers in exposed human populations. This work reviews the available rodent studies considered relevant to carcinogenic assessment of arsenicals, taking advantage of the most recent review by the International Agency for Research on Cancer (IARC) that has not yet appeared as a full monograph but has been summarized (IARC, 2009 , IARC Special Report: Policy, Vol. 10. Lyon: IARC Press, 453–454). Many valid studies show that arsenic can interact with other carcinogens/agents to enhance oncogenesis, and help elucidate mechanisms, and these too are summarized in this review. Finally, this body of rodent work is discussed in light of its impact on mechanisms and in the context of the persistent argument that arsenic is not carcinogenic in animals.
authors.affiliation: National Toxicology Program, National Institute of Environmental Health Sciences, and Laboratory of Comparative Carcinogenesis, National Cancer Institute at the National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
authors.forename: Erik J
authors.initials: EJ
authors.lastname: Tokar
authors.forename: Lamia
authors.initials: L
authors.lastname: Benbrahim-Tallaa
authors.forename: Jerrold M
authors.initials: JM
authors.lastname: Ward
authors.forename: Ruth
authors.initials: R
authors.lastname: Lunn
authors.forename: Reeder L
authors.initials: RL
authors.lastname: Sams
authors.forename: Michael P
authors.initials: MP
authors.lastname: Waalkes
mesh_terms: D000818:Animals; D001151:Arsenic / Q000633:toxicity*; D001152:Arsenicals / Q000009:adverse effects*; D002273:Carcinogens / Q000633:toxicity*; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D008297:Male; D008745:Methylation; D051379:Mice; D008815:Mice, Inbred Strains; D009369:Neoplasms / Q000139:chemically induced*; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D001152:Arsenicals; D002273:Carcinogens; D001151:Arsenic
references.citation: IARC Monogr Eval Carcinog Risks Hum. 2004;84:1-477
references.pmid: 15645577
references.citation: Cancer Sci. 2007 Jun;98(6):803-14
references.pmid: 17441966
references.citation: Cancer Lett. 1998 Mar 13;125(1-2):83-8
references.pmid: 9566700
references.citation: Proc West Pharmacol Soc. 1983;26:413-5
references.pmid: 6688469
references.citation: Environ Res. 1984 Aug;34(2):227-41
references.pmid: 6086305
references.citation: Environ Health Perspect. 2010 Jan;118(1):108-15
references.pmid: 20056578
references.citation: Cancer Lett. 1985 May;27(1):99-104
references.pmid: 4005826
references.citation: Am J Pathol. 1998 Dec;153(6):1775-85
references.pmid: 9846968
references.citation: Toxicol Appl Pharmacol. 2005 Aug 22;207(1):69-77
references.pmid: 16054901
references.citation: Toxicol Appl Pharmacol. 2000 Jul 1;166(1):24-35
references.pmid: 10873715
references.citation: IARC Monogr Eval Carcinog Risks Hum. 2006;87:1-471
references.pmid: 17191367
references.citation: Environ Health Perspect. 2006 Aug;114(8):1293-6
references.pmid: 16882542
references.citation: Toxicol Appl Pharmacol. 2007 Aug 1;222(3):271-80
references.pmid: 17306315
references.citation: Cancer Lett. 2005 Jun 1;223(1):27-35
references.pmid: 15890234
references.citation: Verh Dtsch Ges Pathol. 1971;55:289-93
references.pmid: 4130723
references.citation: Int J Cancer. 1979 Dec 15;24(6):786-8
references.pmid: 544532
references.citation: Natl Toxicol Program Tech Rep Ser. 2000 Sep;492:1-306
references.pmid: 12563348
references.citation: Ann N Y Acad Sci. 2006 Sep;1076:578-91
references.pmid: 17119234
references.citation: Environ Health Perspect. 2004 Apr;112(5):599-603
references.pmid: 15064167
references.citation: Toxicol Appl Pharmacol. 2006 Sep 15;215(3):295-305
references.pmid: 16712894
references.citation: Toxicol Lett. 2005 Aug 14;158(2):87-94
references.pmid: 16039397
references.citation: Toxicology. 2006 Jun 1;223(1-2):82-100
references.pmid: 16677751
references.citation: Lab Invest. 2006 Dec;86(12):1203-7
references.pmid: 17075578
references.citation: Mutat Res. 1997 Jun;386(3):209-18
references.pmid: 9219559
references.citation: IARC Monogr Eval Carcinog Risk Chem Hum. 1980;23:1-415
references.pmid: 6933135
references.citation: Biol Pharm Bull. 2001 May;24(5):510-4
references.pmid: 11379771
references.citation: Carcinogenesis. 1996 Nov;17(11):2435-9
references.pmid: 8968060
references.citation: Toxicology. 2003 Aug 28;190(3):197-219
references.pmid: 12927375
references.citation: Environ Health Perspect. 2000 Jun;108 Suppl 3:573-94
references.pmid: 10852857
references.citation: Toxicol Appl Pharmacol. 2007 Dec 1;225(2):206-13
references.pmid: 17765279
references.citation: Endocr Pathol. 2008 Spring;19(1):9-16
references.pmid: 18317952
references.citation: Toxicol Appl Pharmacol. 2003 Jan 1;186(1):7-17
references.pmid: 12583988
references.citation: Vopr Onkol. 1986;32(3):68-73
references.pmid: 3962260
references.citation: Carcinogenesis. 2003 Nov;24(11):1827-35
references.pmid: 12919961
references.citation: Int J Cancer. 1987 Aug 15;40(2):220-3
references.pmid: 3610389
references.citation: Cancer Lett. 2000 Apr 28;152(1):79-85
references.pmid: 10754209
references.citation: J Pharmacokinet Pharmacodyn. 2008 Feb;35(1):31-68
references.pmid: 17943421
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1982-7
references.pmid: 18708388
references.citation: Carcinogenesis. 2004 Jan;25(1):133-41
references.pmid: 14514661
references.citation: Carcinogenesis. 2003 Feb;24(2):335-42
references.pmid: 12584185
references.citation: Carcinogenesis. 1996 Apr;17(4):767-70
references.pmid: 8625489
references.citation: Curr Opin Biotechnol. 2007 Oct;18(5):460-6
references.pmid: 18023337
references.citation: Cancer Lett. 1983 Dec;21(2):141-7
references.pmid: 6652618
references.citation: Carcinogenesis. 2005 Dec;26(12):2179-86
references.pmid: 16014701
references.citation: Toxicol Appl Pharmacol. 2001 Oct 1;176(1):64-71
references.pmid: 11578149
references.citation: Toxicol Appl Pharmacol. 2007 Aug 1;222(3):258-63
references.pmid: 17109909
references.citation: Cancer Res. 2008 Oct 15;68(20):8278-85
references.pmid: 18922899
references.citation: J Expo Sci Environ Epidemiol. 2009 May;19(4):343-8
references.pmid: 19190673
references.citation: Carcinogenesis. 2002 Aug;23(8):1387-97
references.pmid: 12151359
references.citation: Lancet Oncol. 2009 May;10(5):453-4
references.pmid: 19418618
references.citation: Toxicol Sci. 2006 Jun;91(2):372-81
references.pmid: 16543296
references.citation: Crit Rev Toxicol. 2009;39(8):695-718
references.pmid: 19743946
references.citation: Toxicol Appl Pharmacol. 2007 May 15;221(1):119-28
references.pmid: 17400267
references.citation: Jpn J Cancer Res. 2000 Jun;91(6):579-81
references.pmid: 10874208
references.citation: Mutat Res. 1997 Jun;386(3):181-4
references.pmid: 9219556
references.citation: Cancer Res. 2006 Feb 1;66(3):1337-45
references.pmid: 16452187
references.citation: Cancer Lett. 1998 Dec 11;134(1):29-36
references.pmid: 10381127
references.citation: Toxicol Lett. 2000 Jul 27;116(1-2):27-35
references.pmid: 10906419
references.citation: Carcinogenesis. 1999 Sep;20(9):1873-6
references.pmid: 10469637
references.citation: Toxicol Appl Pharmacol. 2008 Nov 1;232(3):359-68
references.pmid: 18687352
references.citation: Cancer Res. 1995 Mar 15;55(6):1271-6
references.pmid: 7882321
references.citation: IARC Monogr Eval Carcinog Risks Hum Suppl. 1987;7:1-440
references.pmid: 3482203